These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 12338631

  • 1. Intranasal LHRH agonist (Buserelin) after ovulation: a post-coital contraceptive approach.
    Lemay A, Faure N, Labrie F, Fazekas AT.
    Contracept Deliv Syst; 1983 Apr; 4(2):107-25. PubMed ID: 12338631
    [Abstract] [Full Text] [Related]

  • 2. [Clinical observations on LRH-A used for contraception by luteolysis in normal women--analysis of 88 cases].
    Lu RK, Chen HY, Liu Y, Zhang L, He YJ, Ge LJ, Yuan XW, Qui XD.
    Shengzhi Yu Biyun; 1987 Apr; 7(1):39-40, 45-7. PubMed ID: 12341309
    [Abstract] [Full Text] [Related]

  • 3. New contraceptives tested for women and men.
    Stephenson G.
    Res Resour Rep; 1983 May; 7(5):1-4. PubMed ID: 12338626
    [Abstract] [Full Text] [Related]

  • 4. Fertility regulation technology: status and prospects.
    Segal SJ, Nordberg OS.
    Popul Bull; 1977 Mar; 31(6):1-25. PubMed ID: 12335682
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Ultrasonic and hormonal monitoring of the ovaries during mini-dose oral contraception].
    Doyen J, Schaaps JP, Lambotte R.
    Contracept Fertil Sex (Paris); 1987 May; 15(5):529-33. PubMed ID: 12268693
    [Abstract] [Full Text] [Related]

  • 7. Luteinizing hormone releasing hormone analogues for contraception.
    Nillius SJ.
    Clin Obstet Gynaecol; 1984 Dec; 11(3):551-72. PubMed ID: 6391776
    [Abstract] [Full Text] [Related]

  • 8. [Post-coital contraception].
    Serfaty D.
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):359-64. PubMed ID: 12280207
    [Abstract] [Full Text] [Related]

  • 9. Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns.
    Kuhl H, Jung C, Taubert HD.
    Clin Endocrinol (Oxf); 1984 Aug; 21(2):179-88. PubMed ID: 6432376
    [Abstract] [Full Text] [Related]

  • 10. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
    Dubourdieu S, Charbonnel B, Massai MR, Marraoui J, Spitz I, Bouchard P.
    Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
    [Abstract] [Full Text] [Related]

  • 11. Luteinizing hormone-releasing hormone (LHRH) and its analogs for contraception in women: a review.
    Thau RB.
    Contraception; 1984 Feb; 29(2):143-62. PubMed ID: 6426857
    [Abstract] [Full Text] [Related]

  • 12. [Preclinical research and development of norethisterone].
    Mcguire JL, Hahn DW, Philipps A.
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212
    [Abstract] [Full Text] [Related]

  • 13. [Regulation of fertility by anti-hCG vaccines].
    Frydman R, Bellet D.
    Contracept Fertil Sex (Paris); 1987 Sep; 15(9):817-20. PubMed ID: 12281242
    [Abstract] [Full Text] [Related]

  • 14. The search for male contraception. Men are different.
    Steinmann M.
    RF Illus; 1982 Jun; ():29-31. PubMed ID: 12264477
    [Abstract] [Full Text] [Related]

  • 15. Luteolysis in humans and subhuman primates.
    Henzl MR.
    Res Prostaglandins; 1972 May; 1(5):1-3. PubMed ID: 12337004
    [Abstract] [Full Text] [Related]

  • 16. [Contraception with pure, synthetic progestogens of the norpregnane group, a new approach for the future?].
    Rozenbaum H.
    Contracept Fertil Sex (Paris); 1986 Jun; 14(6):577-81. PubMed ID: 12341096
    [Abstract] [Full Text] [Related]

  • 17. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A, Faure N.
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
    [Abstract] [Full Text] [Related]

  • 18. Luteolytic activity of LHRH and [D-Ser(TBU)6, des-Gly-NH2(10)]LHRH ethylamide: a new and physiological approach to contraception in women.
    Lemay A, Labrie F, Raynaud JP.
    Int J Fertil; 1980 Dec; 25(3):203-12. PubMed ID: 6108931
    [Abstract] [Full Text] [Related]

  • 19. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
    Nillius SJ, Bergquist C, Wide L.
    Int J Fertil; 1980 Dec; 25(3):239-46. PubMed ID: 6108935
    [Abstract] [Full Text] [Related]

  • 20. Mid-cycle contraception with LHRH in women.
    Maia H, Barbosa IC, Maia H, Coutinho EM.
    Reproduccion; 1981 Dec; 5(4):251-60. PubMed ID: 7033017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.